Conference Date & Venue

November 7, 2026

Los Angeles, CA

Support Construction of Binaytara's Cancer Hospital in Nepal

Event Description

The 2026 Los Angeles Thoracic Oncology Conference is a premier CME-accredited oncology conference dedicated to advancing the care of patients with non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). This in-person educational summit will gather leading experts and practicing oncology professionals to discuss the most significant advances in thoracic oncology.

With treatment guidelines for lung cancer rapidly evolving—driven by breakthroughs in immunotherapy, targeted agents, antibody–drug conjugates (ADCs), bispecifics, and biomarker-guided diagnostics—oncology providers need practical, timely updates to optimize evidence-based care. This annual conference bridges the gap between research and clinical practice by delivering a highly interactive program that blends expert-led lectures, clinical debates, panel discussions, and breakout case sessions.

 

Target Audience                               

  • Medical Oncologists
  • Surgical Oncologists
  • Radiation Oncologists
  • Pathologists
  • Oncology Fellows
  • Oncology Nurses
  • Nurse Practiotioners
  • Physician Assistants
  • Oncology Pharmacists

 

 

Contact Us   

Phone: 425-361-0029

Email: sponsorships@binaytara.org


 

About Binaytara

Binaytara is a leading global oncology 501(c)(3) nonprofit, dedicated to reducing cancer health disparities around the world. Founded in 2007 by Tara Shah and Dr. Binay Shah, our mission is to improve access to cancer care, enhance continuing medical education (CME), and foster implementation science research in hematology and oncology, thereby reducing the global burden of cancer.

As the largest cancer conference organizer in the US, we impact thousands of doctors and oncology/hematology practitioners who attend our conferences to stay current on cutting-edge treatments for their patients. Binaytara is an accredited CME provider committed to improving patient outcomes through high-quality, independent CME activities for physicians, pharmacists, and nurses. 

As a leader in global oncology, we have partnered with local government and health organizations in Nepal to operate the only cancer hospital in Madhesh Province, deliver cervical cancer screenings, provide nurse training, and establish the first bone marrow transplant center in the country. In India, we have partnered with government institutions to establish hospice and palliative care programs in Madhya Pradesh. We are beginning construction in 2024 on a comprehensive 200-bed cancer center in Janakpur, Nepal that will dramatically improve access to cancer care in Nepal and surrounding communities.

We invite companies interested in improving equitable access to cancer care to support our efforts.